一项新的心脏病协会准则建议,为第2阶段高血压高血压提供含有两剂血压药物的单一药丸,以改善控制并降低心脏病风险。 A new heart association guideline recommends a single pill with two blood pressure drugs for stage 2 hypertension to improve control and reduce heart risks.

美国心脏协会的一份新声明建议,开始使用单一药片进行治疗,同时配以两种针对成年人的血压药物,即第2阶段高血压,因为这种方法可以比单独药片更有效、更快地降低血压。 A new American Heart Association statement recommends starting treatment with a single pill combining two blood pressure medications for adults with stage 2 hypertension, as this approach can lower blood pressure more effectively and quickly than separate pills. 该战略旨在改善遵守情况,减少心脏病发作和中风的风险,特别是考虑到1.22亿高血压的美国成人中只有不到一半达到治疗目标。 The strategy aims to improve adherence and reduce risks of heart attack and stroke, especially given that less than half of the 122 million U.S. adults with high blood pressure reach treatment targets. 该声明强调使用常见药物,如ACE抑制剂、ARBs、钙渠道阻塞剂或亚氨酸盐等的简化疗法的好处,尽管它指出需要对长期结果和执行情况进行更多的研究。 The statement emphasizes the benefits of simplified regimens using common drugs like ACE inhibitors, ARBs, calcium channel blockers, or diuretics, though it notes the need for more research on long-term outcomes and implementation.